(1)
Sahakyan, Y.; Erman, A. .; Bhojani, N. .; Chughtai, B. .; Zorn, K. C.; Sander, B.; Elterman, D. S. Cost-Utility of Minimally Invasive Therapies Vs. Pharmacotherapy As Initial Therapy for Benign Prostatic Hyperplasia: A Canadian Healthcare Payer Perspective. CUAJ 2022, 17, 103-10.